Business Segments Boston Scientific Corporation
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.35 USD | -2.25% |
|
-7.16% | -25.17% |
| 06/03 | Profound Medical Corp. Announces Board Changes, Effective March 5, 2026 | CI |
| 04/03 | China Merchants Initiates Boston Scientific at Buy With $88 Price Target | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | ||||||||||
Cardiovascular (Incl. Rhythm) | 485.8Cr | 783.1Cr | 881.9Cr | 1.08TCr | 1.32TCr | |||||
Total Assets | 282.1Cr | 520.5Cr | 598.8Cr | 708.4Cr | 799.9Cr | |||||
D&A | 17Cr | 24Cr | 26Cr | 30Cr | 36Cr | |||||
Operating Income | 144.8Cr | 211.3Cr | 223.5Cr | 314.7Cr | 430.3Cr | |||||
MedSurg | 372.4Cr | 491.1Cr | 542.2Cr | 599.3Cr | 682.4Cr | |||||
Total Assets | 179.4Cr | 250.1Cr | 288.8Cr | 309.3Cr | 339.2Cr | |||||
D&A | 8.1Cr | 8.8Cr | 10Cr | 11Cr | 12Cr | |||||
Operating Income | 139.9Cr | 162.5Cr | 179.6Cr | 204.6Cr | 226.8Cr | |||||
Rhythm and Neuro | 329.3Cr | - | - | - | - | |||||
Total Assets | 198.1Cr | - | - | - | - | |||||
D&A | 10Cr | - | - | - | - | |||||
Operating Income | 61Cr | - | - | - | - | |||||
Rhythm Management | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Pharmaceutical Products | ||||||||||
Specialty Pharmaceuticals | 1.3Cr | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | 40L | - | - | - | - | |||||
Other | - | -6Cr | - | - | - | |||||
Operating Income | - | -6Cr | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | -45Cr | -44Cr | -29Cr | -66Cr | -96Cr | |||||
Total Assets | 1.2TCr | 1.29TCr | 1.44TCr | 1.71TCr | 1.83TCr | |||||
Total Assets | 612.1Cr | 590.2Cr | 600.3Cr | 668.4Cr | 701.9Cr | |||||
Total Assets | 752.5Cr | 594.1Cr | 586.9Cr | 544.6Cr | 698.1Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S.) | 691.1Cr | 763.2Cr | 842.5Cr | 1.02TCr | 1.29TCr | |||||
Total Assets | 119Cr | 124.1Cr | 130Cr | 146.1Cr | 191.9Cr | |||||
Europe, Middle East and Africa (EMEA) | 251.8Cr | 252.6Cr | 285.6Cr | 322.8Cr | 345.1Cr | |||||
Asia-Pacific (APAC) | 207Cr | 211.6Cr | 240Cr | 268.6Cr | 308Cr | |||||
Latin America and Canada (LACA) | 39Cr | 47Cr | 56Cr | 62Cr | 68Cr | |||||
Total Assets | 1.85TCr | 1.92TCr | 2.08TCr | 2.42TCr | 2.58TCr | |||||
Total Assets | - | 25Cr | 37Cr | 53Cr | 64Cr | |||||
International | 40L | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Other Countries | - | -6Cr | - | - | - | |||||
Total Assets | 62Cr | 48Cr | 59Cr | 67Cr | 73Cr | |||||
Total Assets | 44Cr | 48Cr | 60Cr | 63Cr | 75Cr | |||||
Japan | - | - | - | - | - |
- Stock Market
- Equities
- BSX Stock
- Financials Boston Scientific Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition